BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $49.00
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target lifted by Citigroup from $45.00 to $49.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other research analysts also recently commented on the stock. Bank of America increased their target price […]
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target lifted by Citigroup from $45.00 to $49.00 in a research report released on Friday morning,Benzinga reports. The brokerage currently has a buy rating on the stock. A number of other research analysts also recently commented on the stock. Bank of America increased their target price […]
